MDDiabeticPro
Discover, Control & Prevent diabetic risk.
How does MDDiabeticPro differ from other diabetes tests?
PMLS offers a variety of biomarkers on our diabetes test panel. Besides running a normal A1C test, PMLS goes further and tests a patient’s Fasting Glucose, GlycoMark, Adiponectin, Leptin, HOMA-IR, Insulin, and C-peptide, but we don’t stop there. To give patient’s a look at the bigger picture, we also run a Comorbidity Assessment of Cardiovascular and Renal biomarkers, as well as a Genetic Predisposition test called DIABETESpredict™. With DIABETESpredict™, doctors can help their patients know their risk for type 2 diabetes earlier.
MdDiabeticPro is also specifically designed to help Type 1 diabetes patients with the management of the disease. This test can be used for monitoring individuals who are pre-disposed to insulin resistance. The results of the test equip physicians with the information needed to fine tune nutrition and exercise plans, helping a T1D patient to make the use of insulin most effective.
Know your risk with DIABETESPredict™
DIABETESpredict™ is a genotyping tool for type 2 diabetes risk assessment. It analyzes the main genetic variants associated with T2D, taking into account multi-ethnic associations. DIABETESpredict™ identifies high risk individuals and gives them additional information to implement lifestyle changes. Early identification of type 2 diabetes enables prevention and with DIABETESpredict™ doctors are empowered to help their patients further.
500 Million worldwide suffer
type-2 diabetes.
34.2 Million Americans, or 10.5% of the population, had diabetes.
Let’s Talk
We want to hear from you! Tell us more about your interest in MDChemistryPro today.
Read Our Blog
Next Generation Sequencing Solutions: COVID-19 (SARS-CoV-2) whole-genome sequencing, non-invasive prenatal diagnosis, and cancer screening.
Here at Premier Medical Laboratory Services (PMLS), our mission is to help physicians provide the best care to their patients while remaining an industry leader through cutting-edge technology and scientific innovation. Our Next...
Former Congressman Joe Cunningham and Senator Tim Scott’s Office Visit South Carolina’s Largest Laboratory, PMLS
In the past few months at Premier Medical Laboratory Services, we have had the pleasure of welcoming a few South Carolina politicians and their staff to our headquarters in Greenville, SC. Alongside Lindsey Graham's visit, two of the visits were from former...
U.S. Senator Lindsey Graham Speaks on The Importance of Variant Tracking During Tour of PMLS
~ Premier Medical Laboratory Services is conducting one of the largest-scale Next Generation Sequencing initiatives in the nation for variant tracking ~ Greenville, SC June, 17 2021 – US Senator Lindsey Graham recently viewed one of the largest variant surveillance...
Rutgers University and Premier Medical Laboratory Services Conduct Studies Showing TAG-NGPM+™ Inactivates SARS CoV-2 Virus, Increases Stability
~ Together, Rutgers and Premier are publishing a scientific article demonstrating their findings ~ Public Health Research Institute at Rutgers New Jersey Medical School and Premier Medical Laboratory Services (PMLS) have conducted studies on the stability and viral...
Nation-Leading COVID-19 Variant Surveillance Initiative Now Underway: Premier Medical Laboratory Services
The Biden Administration recently announced a $1.7 billion investment to monitor new and emerging COVID-19 variants which could induce another pandemic wave. Concurrently, to combat these mutated strains, advanced molecular diagnostics laboratory, Premier Medical...
PMLS Awarded: Healthcare Tech Outlook Top Genetic Diagnostic Solution Providers of 2021
Premier Medical Laboratory Services is designated as a top Genetic Diagnostic Solution Provider of 2021. This award comes as recognition for our laboratory's contributions to improving overall patient care with the most advanced diabetes and cardiovascular testing and...